Insight Molecular Diagnostics Price to Book Ratio 2014-2025 | IMDX
Historical price to book ratio values for Insight Molecular Diagnostics (IMDX) over the last 10 years. The current price to book ratio for Insight Molecular Diagnostics as of July 11, 2025 is 8.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Insight Molecular Diagnostics Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2025-07-11 | 2.86 | 8.00 | |
| 2025-03-31 | 3.06 | $0.36 | 8.56 |
| 2024-12-31 | 2.38 | $-0.70 | -3.38 |
| 2024-09-30 | 2.85 | $0.73 | 3.93 |
| 2024-06-30 | 2.95 | $1.70 | 1.74 |
| 2024-03-31 | 2.93 | $1.40 | 2.09 |
| 2023-12-31 | 2.50 | $2.48 | 1.01 |
| 2023-09-30 | 3.12 | $4.55 | 0.69 |
| 2023-06-30 | 4.60 | $5.29 | 0.87 |
| 2023-03-31 | 7.08 | $6.36 | 1.11 |
| 2022-12-31 | 6.42 | $5.78 | 1.11 |
| 2022-09-30 | 14.60 | $12.96 | 1.13 |
| 2022-06-30 | 18.00 | $14.04 | 1.28 |
| 2022-03-31 | 29.80 | $12.35 | 2.41 |
| 2021-12-31 | 43.40 | $14.14 | 3.07 |
| 2021-09-30 | 71.20 | $21.56 | 3.30 |
| 2021-06-30 | 114.80 | $22.73 | 5.05 |
| 2021-03-31 | 103.80 | $23.98 | 4.33 |
| 2020-12-31 | 47.80 | $9.69 | 4.93 |
| 2020-09-30 | 27.80 | $10.30 | 2.70 |
| 2020-06-30 | 38.20 | $11.78 | 3.24 |
| 2020-03-31 | 49.00 | $11.72 | 4.18 |
| 2019-12-31 | 45.00 | $10.81 | 4.16 |
| 2019-09-30 | 42.00 | $11.29 | 3.72 |
| 2019-06-30 | 49.80 | $12.89 | 3.86 |
| 2019-03-31 | 79.00 | $14.69 | 5.38 |
| 2018-12-31 | 27.60 | $1.68 | 16.39 |
| 2018-09-30 | 50.00 | $3.70 | 13.51 |
| 2018-06-30 | 51.00 | $3.47 | 14.68 |
| 2018-03-31 | 42.00 | $4.77 | 8.80 |
| 2017-12-31 | 93.00 | $2.80 | 33.22 |
| 2017-09-30 | 151.00 | $5.12 | 29.47 |
| 2017-06-30 | 104.00 | $3.82 | 27.22 |
| 2017-03-31 | 119.00 | $5.97 | 19.92 |
| 2016-12-31 | 141.00 | $6.86 | 20.54 |
| 2016-09-30 | 100.80 | $8.84 | 11.40 |
| 2016-06-30 | 71.20 | $3.51 | 20.27 |
| 2016-03-31 | 92.20 | $5.43 | 16.99 |
| 2015-12-31 | 125.00 | $8.21 | 15.23 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.082B | $0.002B |
| Insight Molecular Diagnostics Inc. is a pioneering diagnostics technology company. Insight Molecular Diagnostics Inc., formerly known as Oncocyte Corporation, is based in NASHVILLE, Tenn. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $45.084B | 57.36 |
| Doximity (DOCS) | United States | $11.307B | 52.35 |
| Hims & Hers Health (HIMS) | United States | $10.719B | 111.37 |
| Tempus AI (TEM) | United States | $9.847B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.340B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.842B | 60.03 |
| Hinge Health (HNGE) | United States | $3.717B | 0.00 |
| Privia Health (PRVA) | United States | $2.496B | 170.58 |
| Enovis (ENOV) | United States | $1.944B | 10.84 |
| Phreesia (PHR) | United States | $1.590B | 0.00 |
| 10x Genomics (TXG) | United States | $1.576B | 0.00 |
| Schrodinger (SDGR) | United States | $1.542B | 0.00 |
| Azenta (AZTA) | United States | $1.532B | 71.21 |
| Clover Health Investments (CLOV) | United States | $1.486B | 0.00 |
| Omnicell (OMCL) | United States | $1.344B | 23.71 |
| Evolent Health (EVH) | United States | $1.313B | 111.80 |
| Claritev (CTEV) | United States | $0.761B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.587B | 0.00 |
| Veradigm (MDRX) | United States | $0.547B | 0.00 |
| Standard BioTools (LAB) | United States | $0.501B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.448B | 0.00 |
| Talkspace (TALK) | United States | $0.442B | 132.00 |
| Outset Medical (OM) | United States | $0.344B | 0.00 |
| TruBridge (TBRG) | United States | $0.331B | 735.33 |
| Health Catalyst (HCAT) | United States | $0.271B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.258B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.233B | 0.00 |
| CapsoVision (CV) | United States | $0.212B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.161B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.150B | 0.00 |
| American Well (AMWL) | United States | $0.131B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.123B | 0.00 |
| Pulmonx (LUNG) | United States | $0.117B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.103B | 0.00 |
| CareCloud (CCLD) | United States | $0.101B | 3.84 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.068B | 0.00 |
| 111 (YI) | China | $0.065B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.045B | 0.00 |
| HeartBeam (BEAT) | United States | $0.042B | 0.00 |
| Zhongchao (ZCMD) | China | $0.029B | 0.00 |
| Precipio (PRPO) | United States | $0.024B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.009B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.005B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |